Cargando…

Gallbladder cancer: current and future treatment options

Surgery remains the preferred treatment option for early-stage gallbladder cancer (GBC). According to the anatomical position of the primary tumor, accurate preoperative stage and strict control of surgical indications, appropriate surgical strategies are selected to achieve the optimal surgical eff...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Yanzhao, Yuan, Kun, Yang, Yi, Ji, Zemin, Zhou, Dezheng, Ouyang, Jingzhong, Wang, Zhengzheng, Wang, Fuqiang, Liu, Chang, Li, Qingjun, Zhang, Qi, Li, Qiang, Shan, Xiao, Zhou, Jinxue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213899/ https://www.ncbi.nlm.nih.gov/pubmed/37251319 http://dx.doi.org/10.3389/fphar.2023.1183619

Ejemplares similares

Challenges Facing Percutaneous Ablation in the Treatment of Hepatocellular Carcinoma: Extension of Ablation Criteria
por: Zhou, Yanzhao, et al.
Publicado: (2021)

Adjuvant Lenvatinib Plus PD-1 Antibody for Hepatocellular Carcinoma with High Recurrence Risks After Hepatectomy: A Retrospective Landmark Analysis
por: Ouyang, Jingzhong, et al.
Publicado: (2023)

Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives
por: Sarkar, Chandan, et al.
Publicado: (2020)

Using immunovascular characteristics to predict very early recurrence and prognosis of resectable intrahepatic cholangiocarcinoma
por: Xu, Ying, et al.
Publicado: (2023)

Traditional Chinese Medicine is an Alternative Therapeutic Option for Treatment of Pseudomonas aeruginosa Infections
por: Pang, Zheng, et al.
Publicado: (2021)

A CT-based radiomics approach to predict intra-tumoral tertiary lymphoid structures and recurrence of intrahepatic cholangiocarcinoma
por: Xu, Ying, et al.
Publicado: (2023)

An overview of the past decade of bufalin in the treatment of refractory and drug-resistant cancers: current status, challenges, and future perspectives
por: Ye, Qingmei, et al.
Publicado: (2023)

Renal function protection and the mechanism of ginsenosides: Current progress and future perspectives
por: Fan, Meiling, et al.
Publicado: (2023)

Current State and Future Directions of Intranasal Delivery Route for Central Nervous System Disorders: A Scientometric and Visualization Analysis
por: Wu, Haiyang, et al.
Publicado: (2021)

Yisaipu(®) Provide AS Patients With an Economical Therapeutic Option While Original Biologicals are More Advantageous in the COVID-19 Epidemic Situation
por: Lu, Hongjuan, et al.
Publicado: (2021)

Mannose: A Sweet Option in the Treatment of Cancer and Inflammation
por: Nan, Fang, et al.
Publicado: (2022)

Combining Immunotherapy and Radiotherapy for Cancer Treatment: Current Challenges and Future Directions
por: Wang, Yifan, et al.
Publicado: (2018)

Current Treatment Options and Therapeutic Insights for Gastrointestinal Dysmotility and Functional Gastrointestinal Disorders
por: Singh, Rajan, et al.
Publicado: (2022)

Current Evidence and Future Directions of Berberine Intervention in Depression
por: Zhu, Wen-Qian, et al.
Publicado: (2022)

Astragalus and its formulas as a therapeutic option for fibrotic diseases: Pharmacology and mechanisms
por: Zhu, Yi, et al.
Publicado: (2022)

CD226 Is Required to Maintain Megakaryocytes/Platelets Homeostasis in the Treatment of Knee Osteoarthritis With Platelet-Rich Plasma in Mice
por: Liu, Yongming, et al.
Publicado: (2021)

Active Components of Traditional Chinese Medicinal Material for Multiple Myeloma: Current Evidence and Future Directions
por: Yu, Chao-Chao, et al.
Publicado: (2022)

Crocins for Ischemic Stroke: A Review of Current Evidence
por: Shahbaz, Kiran, et al.
Publicado: (2022)

Apatinib for recurrent/progressive glioblastoma multiforme: A salvage option
por: Zhang, Hong-Hong, et al.
Publicado: (2022)

Current Drug Treatment Strategies for Atrial Fibrillation and TASK-1 Inhibition as an Emerging Novel Therapy Option
por: Kraft, Manuel, et al.
Publicado: (2021)

Targeting Mutant Kirsten Rat Sarcoma Viral Oncogene Homolog in Non-Small Cell Lung Cancer: Current Difficulties, Integrative Treatments and Future Perspectives
por: Li, Jia-Xin, et al.
Publicado: (2022)

OMICS Applications for Medicinal Plants in Gastrointestinal Cancers: Current Advancements and Future Perspectives
por: Dai, Rongchen, et al.
Publicado: (2022)

Current State and Future Prospects of Direct-to-Consumer Pharmacogenetics
por: Chua, E. W., et al.
Publicado: (2012)

Traditional medicines and globalization: current and future perspectives in ethnopharmacology
por: Leonti, Marco, et al.
Publicado: (2013)

Editorial: Drug Repositioning: Current Advances and Future Perspectives
por: Nishimura, Yuhei, et al.
Publicado: (2018)

Current and future therapies to treat impaired awareness of hypoglycemia
por: Macon, Erica L., et al.
Publicado: (2023)

The Current Application and Future Prospects of Astragalus Polysaccharide Combined With Cancer Immunotherapy: A Review
por: Kong, Fanming, et al.
Publicado: (2021)

The protective effects of baicalin for respiratory diseases: an update and future perspectives
por: Song, Siyu, et al.
Publicado: (2023)

Cost-Utility Analysis: Current Methodological Issues and Future Perspectives
por: Nuijten, Mark J. C., et al.
Publicado: (2011)

Erlotinib Resistance in Lung Cancer: Current Progress and Future Perspectives
por: Tang, Joy, et al.
Publicado: (2013)

Adenosine Receptor-Mediated Cardioprotection—Current Limitations and Future Directions
por: Lasley, Robert D.
Publicado: (2018)

Cellular Senescence and Senotherapies in the Kidney: Current Evidence and Future Directions
por: Docherty, Marie Helena, et al.
Publicado: (2020)

The Therapeutic Landscape of Rheumatoid Arthritis: Current State and Future Directions
por: Shams, Shahin, et al.
Publicado: (2021)

Nutraceuticals in the Modulation of the Intestinal Microbiota: Current Status and Future Directions
por: Spisni, Enzo, et al.
Publicado: (2022)

Photodynamic therapy in pediatric age: Current applications and future trends
por: Di Bartolomeo, Luca, et al.
Publicado: (2022)

Recent Advances in Clinical Diagnosis and Pharmacotherapy Options of Membranous Nephropathy
por: Wang, Yan-Ni, et al.
Publicado: (2022)

Current and future treatment options in SIADH
por: Zietse, Robert, et al.
Publicado: (2009)

EUS-guided gallbladder drainage: Current status and future prospects
por: Adler, Douglas G.
Publicado: (2018)

Gallbladder Cancer: Current Multimodality Treatment Concepts and Future Directions
por: Sturm, Niklas, et al.
Publicado: (2022)

miR-96 exerts carcinogenic effect by activating AKT/GSK-3β/β-catenin signaling pathway through targeting inhibition of FOXO1 in hepatocellular carcinoma
por: Yang, Nanmu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_q41pp2oq43on3bgu7av9e1dcov